| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -55.34M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TNGX returned +246.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +169.5% |
| 1 year | +246.1% |
| 5 years | +105.2% |
| All-time high | $31.26 (Jun 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TNGX would be worth today ›No. Tango Therapeutics, Inc. has not paid a dividend in the past 12 months.
Tango Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol TNGX.
Tango Therapeutics, Inc. is part of the Healthcare sector.
Tango Therapeutics, Inc. has a market cap of 4.03B USD, based on the latest quote.
Tango Therapeutics, Inc. is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
